LIN-31 activators encompass a specialized group of molecules designed to engage with and enhance the activity of the LIN-31 protein, which is a transcription factor involved in the regulation of developmental processes. LIN-31 belongs to a class of Forkhead Box (FOX) proteins, characterized by a distinct DNA-binding domain known as the Forkhead box or winged-helix domain. This domain enables the protein to bind specific DNA sequences, thereby controlling the transcription of genes that are crucial for the development and differentiation of cells. Activators of LIN-31 are characterized by their ability to increase the DNA-binding activity of LIN-31 or to facilitate its interaction with other co-factors, leading to an upregulation of gene expression. The chemical structures of LIN-31 activators are diverse, reflecting the complexity of the protein's regulation. These structures are specifically tailored to interact with LIN-31 in a way that promotes its function as a transcriptional regulator. The specificity and affinity of these activators for LIN-31 are paramount, as they determine the precision and effectiveness with which these compounds can modulate the activity of the protein.
The study of LIN-31 activators is rooted in a deep interest in deciphering the regulatory mechanisms of gene expression during development. By understanding how these activators influence LIN-31 activity, scientists can gain insights into the intricate network of signals that govern developmental pathways. The molecular interaction between LIN-31 activators and the protein itself can lead to alterations in the protein's conformation, modulate its stability, or affect its interactions with other regulatory proteins within the cell. Researchers focus on various properties of LIN-31 activators, such as their molecular structure, the dynamics of their binding to LIN-31, and the consequent effects on the transcriptional regulatory functions of the protein. Through such studies, a clearer picture emerges of how transcription factors are controlled within the cell and how they execute their roles in orchestrating the complex processes of development. The knowledge gleaned from examining LIN-31 activators thus contributes to the fundamental understanding of gene regulation and the molecular basis of cell differentiation and organismal development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
By inhibiting GSK-3, LiCl can activate the Wnt signaling pathway, which might lead to increased LIN-31 expression. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
BIO is a GSK-3 inhibitor that can mimic Wnt signaling activation, potentially upregulating LIN-31. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT inhibits gamma-secretase, an enzyme involved in Notch signaling; it may alter LIN-31 expression by modulating this pathway. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression and could influence the Notch signaling pathway, thereby affecting LIN-31 levels. | ||||||
IWR-1-endo | 1127442-82-3 | sc-295215 sc-295215A | 5 mg 10 mg | $82.00 $135.00 | 19 | |
IWR-1 stabilizes the destruction complex of beta-catenin, which may lead to changes in LIN-31 expression via Wnt pathway modulation. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV-939 inhibits Wnt pathway signaling by promoting beta-catenin degradation, which could indirectly affect LIN-31 expression. | ||||||
Dibenzazepine (Deshydroxy LY 411575) | 209984-56-5 | sc-207554 sc-207554A | 2 mg 5 mg | $235.00 $260.00 | 4 | |
DBZ is a potent gamma-secretase inhibitor, impacting Notch signaling and potentially altering LIN-31 expression. | ||||||
JW 55 | 664993-53-7 | sc-364517 sc-364517A | 10 mg 50 mg | $172.00 $726.00 | ||
JW55 antagonizes the Wnt/beta-catenin signaling, and thus could modulate LIN-31 expression indirectly. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
LGK-974 is a Porcupine inhibitor, affecting Wnt ligand secretion and potentially altering LIN-31 expression. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
CHIR99021 is a GSK-3 inhibitor leading to Wnt signaling activation, which may impact LIN-31 expression levels. | ||||||